Application 207503
- Type
- ANDA
- Sponsor
- BRECKENRIDGE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ACETAZOLAMIDE | ACETAZOLAMIDE | TABLET;ORAL | 125MG | No | No |
| 002 | ACETAZOLAMIDE | ACETAZOLAMIDE | TABLET;ORAL | 250MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207503-001 | ACETAZOLAMIDE | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | ||
| A207503-002 | ACETAZOLAMIDE | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | 2020-04-30 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | 2020-04-30 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | AB | 2020-04-30 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | 2020-04-30 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | AB | 2020-04-30 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | 2020-04-30 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | AB | 2020-04-30 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | 2020-04-30 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207503-001 | ACETAZOLAMIDE | 125MG | TABLET / ORAL | AB | 2020-04-30 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207503-002 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | 2020-04-30 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207503-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207503-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A207503-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A207503-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A207503-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A207503-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A207503-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A207503-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A207503-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A207503-002 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207503-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207503-002 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A207503-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A207503-002 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A207503-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A207503-002 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A207503-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A207503-002 | AB | 1 | c0c555d07b60… |
| 2023-01-26 05:58 UTC | 2023-01 | A207503-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A207503-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207503-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207503-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A207503-001 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A207503-002 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A207503-001 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A207503-002 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A207503-001 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A207503-002 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetazolamide | ACETAZOLAMIDE | NuCare Pharmaceuticals,Inc. | 0b76c194-b244-e9ac-e063-6394a90a373e | 2025-02-03 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | NuCare Pharmaceuticlas, Inc. | 278878bc-da9c-09d4-e063-6394a90abaf7 | 2024-11-22 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Bryant Ranch Prepack | 923031ec-8142-4570-b3a6-210441d97105 | 2024-10-29 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Chartwell RX, LLC | e8e48a25-5f6c-4b5a-a5f2-ee87aabea33b | 2024-10-10 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Chartwell RX, LLC | f75bbf55-98ac-4f91-b6fd-17b5ac860e55 | 2024-10-10 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| acetazolamide | ACETAZOLAMIDE | Zydus Pharmaceuticals (USA) Inc. | bf514e99-4958-44a0-a87a-02a950f87e60 | 2024-10-08 | Warnings, Adverse reactions | acetazolamide ACETAZOLAMIDE |
| acetazolamide | ACETAZOLAMIDE | Zydus Lifesciences Limited | 2c1d9078-c15f-4dce-bc26-edfa5400fa9b | 2024-10-08 | Warnings, Adverse reactions | acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Alembic Pharmaceuticals Inc. | 43231abb-2a5d-44ab-b3e6-7564a1131ac5 | 2024-09-30 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| acetaZOLAMIDE | ACETAZOLAMIDE | NuCare Pharmaceuticals,Inc. | 1b2c973f-82ef-a4f3-e063-6394a90aaae0 | 2024-08-09 | Warnings, Adverse reactions | acetaZOLAMIDE ACETAZOLAMIDE |
| acetaZOLAMIDE | ACETAZOLAMIDE | Zydus Pharmaceuticals (USA) Inc. | 85e4d8f6-1e82-4068-a768-752287d4ccf2 | 2024-03-26 | Warnings, Adverse reactions | acetaZOLAMIDE ACETAZOLAMIDE |
| ACETAZOLAMIDE | ACETAZOLAMIDE | TRUPHARMA, LLC | 4fcd428a-7bf3-4e75-a834-1bdf1078107f | 2022-06-13 | Warnings, Adverse reactions | ACETAZOLAMIDE ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Proficient Rx LP | 3cdde6aa-c89d-4ea4-aade-6c8b5c3ffdcc | 2019-10-01 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Alembic Pharmaceuticals Limited | d9c1cc75-4e3d-4eaf-87c5-d5942a843818 | 2019-02-20 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51991-884 | AcetaZOLAMIDE | Acetazolamide | Breckenridge Pharmaceutical, Inc. | ANDA | Current |
| 51991-884 | AcetaZOLAMIDE | Acetazolamide | Breckenridge Pharmaceutical, Inc. | ANDA | Current |
| 51991-885 | AcetaZOLAMIDE | Acetazolamide | Breckenridge Pharmaceutical, Inc. | ANDA | Current |
| 51991-885 | AcetaZOLAMIDE | Acetazolamide | Breckenridge Pharmaceutical, Inc. | ANDA | Current |